Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
Kefah Mokbel, Professor of Medicine (Honorary) at Cardiff University School of Medicine, shared a post on LinkedIn about a recent article by Sedat Carkit et al., published in Scientific Reports, adding:
“Beyond Thromboprophylaxis: Enoxaparin’s Emerging Anticancer Signal
A new study in Scientific Reports adds to the growing evidence that enoxaparin – long used simply to manage cancer-associated thrombosis – may have direct effects on tumour biology.
Using MDA-MB-231 (breast) and HepG2 (liver) cancer cell lines alongside non-cancerous HEK-293 controls, the authors treated cells with a range of enoxaparin concentrations and found:
- Significantly reduced viability in both cancer cell lines, with no cytotoxicity in normal cells
- Markedly increased apoptosis on TUNEL analysis
- Increased LC3/p62 expression, indicating activation of autophagy
- Differential inflammatory modulation – NF-κB rose in breast cancer cells alongside suppression of IL-6 and TNF-α, while liver cancer cells showed no significant inflammatory change
- Reduced extracellular 8-OHdG, suggesting less oxidative DNA damage
The selectivity – hitting cancer cells while sparing normal cells – is what makes this interesting. It’s in-vitro work, so it doesn’t change clinical practice today, but it strengthens the rationale for exploring enoxaparin’s role beyond thromboprophylaxis in oncology.”
Title: Enoxaparin induces apoptosis and autophagy, modulates inflammatory signaling, and reduces oxidative DNA damage in breast and liver cancer cells
Authors: Sedat Carkit, Münevver Baran, Nazmiye Bitgen, Gozde Ozge Onder, Damla Gündüz, Arzu Yay
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 2, 2026, 07:02Christoph B. Olivier: Rapid Platelet Inhibition in Acute Coronary Syndromes
-
Sep 2, 2026, 06:38Gene Therapy for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Sep 2, 2026, 06:32Sanjay Batra: Exploring What Lies Beyond Platelet Counts
-
Sep 2, 2026, 06:22Wolfgang Miesbach: A New Guideline for Critical Bleeding in ITP
-
Sep 2, 2026, 06:03Clémentine Sarkozy: A New Chapter for Hematology at Institut Curie
-
Sep 1, 2026, 18:13Ramsha Batool: Chemotherapy-Induced Anemia Impacts Quality of Life in Breast Cancer
-
Sep 1, 2026, 18:09Natalya Shynhera: Using Anemia to Teach Medical English in Real Clinical Practice
-
Sep 1, 2026, 18:06Wei Du: New Therapeutic Potential for PARP Inhibitors in MLL-Rearranged Leukemia
-
Sep 1, 2026, 18:03Tobias Tichelbäcker: PRAGUE-26 Shows Catheter Lysis Beats Anticoagulation Without Ultrasound